Apellis Pharmaceuticals APLS
$ 30.76
10.85%
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиКвартальный отчет 2024-Q3
добавлен 05.11.2024
Apellis Pharmaceuticals Мультипликаторы 2011-2024 | APLS
Мультипликаторы по годам Apellis Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-15.7 | -9.9 | -4.6 | -9.6 | -8.5 | -5.8 | -5.0 | - | - | - | - | - | - |
P/S |
20.9 | 85.5 | 51.1 | 13.3 | - | - | - | - | - | - | - | - | - |
EPS |
-4.5 | -6.2 | -8.8 | -4.6 | -4.9 | -2.3 | -3.7 | -3.2 | -8.0 | - | - | - | - |
EV (Enterprise Value) |
8.52 млрд | 6.49 млрд | 3.44 млрд | 3.52 млрд | 2.59 млрд | 604 млн | 111 млн | -21.2 млн | 3.2 млн | 1.08 млн | 677 тыс. | - | - |
EBITDA per Share |
-4.34 | -5.59 | -6.34 | -2.84 | -4.62 | -2.3 | -3.66 | - | - | - | - | - | - |
EV/EBITDA |
-6.4 | -14.7 | -8.2 | -4.7 | -2.1 | - | - | - | - | - | - | ||
PEG |
- | 0.74 | 0.08 | -0.16 | 0.03 | - | - | - | - | - | - | ||
P/B |
42.5 | 38.0 | 17.1 | 16.3 | 75.5 | 4.6 | 1.7 | - | - | - | - | - | - |
P/CF |
-13.9 | -12.5 | -6.0 | -20.7 | -12.1 | -5.6 | -5.4 | - | - | - | - | - | - |
ROE % |
-271.76 | -383.92 | -375.69 | -168.60 | -890.18 | -79.21 | -34.25 | - | - | - | - | - | - |
ROA % |
-67.02 | -85.79 | -84.64 | -35.90 | -78.28 | -62.64 | -28.01 | - | - | - | - | - | - |
ROCE % |
-265.84 | -350.04 | -269.94 | -104.48 | -89.03 | -68.59 | -28.91 | - | - | - | - | - | - |
Current Ratio |
1.3 | 1.3 | 1.3 | 1.3 | 5.7 | 11.9 | 27.8 | - | - | - | - | - | - |
DSO |
98.6 | 43.1 | 27.7 | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
98.5 | 43.1 | 27.7 | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
98.5 | 43.1 | 27.7 | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Apellis Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.46 | -0.3 | -0.54 | - | -1.17 | -1.02 | -1.56 | - | -1.75 | -1.46 | -1.42 | - | -2.28 | -2.72 | -2.32 | 1.03 | -1.79 | -1.57 | -2.29 | -1.77 | -1.1 | -1.12 | -0.87 | -0.65 | -0.64 | -0.61 | -0.43 | -0.61 | -1.37 | -1.44 | -1.07 | -3.22 | -0.86 | -0.41 | -0.33 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -501 | - | - | - | -1.53 тыс. | - | -1.39 тыс. | -1.39 тыс. | -1.31 тыс. | - | -1.48 тыс. | -2.4 тыс. | -1.57 | 1.71 | -1.71 | -1.53 | -1.34 | -1.66 | -1.09 тыс. | -1 тыс. | -840 | -0.66 | -0.64 | -0.61 | -0.43 | -0.36 | -1.37 | -1.44 | -1.07 | -0.74 | -0.86 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-123.76 | -159.91 | -180.99 | -138.85 | -201.06 | -202.91 | -120.93 | -45.63 | 295.53 | 698.91 | 807.18 | 140.55 | 178.81 | -228.69 | -441.59 | -168.60 | -537.62 | -675.28 | -824.98 | -890.20 | -582.08 | -400.44 | -213.46 | -79.21 | -68.81 | -54.24 | -41.67 | -34.25 | -49.81 | -72.34 | -64.20 | -58.13 | -30.30 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-35.66 | -46.43 | -55.59 | -48.63 | -70.54 | -75.31 | -77.54 | -49.60 | -86.80 | -102.09 | -117.85 | -91.19 | -83.04 | -59.97 | -41.00 | -35.90 | -73.14 | -76.95 | -82.86 | -78.28 | -67.11 | -66.84 | -64.96 | -62.64 | -54.75 | -43.44 | -33.72 | -28.01 | -42.11 | -62.04 | -55.39 | -50.42 | -26.28 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-113.38 | -152.46 | -176.19 | -136.37 | -186.12 | -176.85 | -97.54 | -33.21 | 190.07 | 463.09 | 555.96 | 119.41 | 183.02 | -103.59 | -297.37 | -104.48 | -477.60 | -618.62 | -747.59 | -841.44 | -555.04 | -372.93 | -208.29 | -79.47 | -68.44 | -53.98 | -41.33 | -34.08 | -48.26 | -70.88 | -62.74 | -56.66 | -30.40 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
1.4 | 1.4 | 1.5 | 1.3 | 1.4 | 1.6 | 1.7 | 1.3 | 1.5 | 1.5 | 1.7 | 1.3 | 0.9 | 0.8 | 1.1 | 1.3 | 1.3 | 1.3 | 1.3 | 1.1 | 1.1 | 1.1 | 1.1 | 4.8 | 4.8 | 4.8 | 4.8 | 5.5 | 5.5 | 5.5 | 5.5 | 7.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
135.2 | 130.8 | 125.6 | - | 115.8 | 68.4 | 39.9 | - | 32.3 | 38.7 | 52.1 | - | 34.2 | 52.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
135.2 | 130.8 | 125.6 | - | 115.8 | 68.4 | 39.9 | - | 32.3 | 38.7 | 52.1 | - | 34.2 | 52.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
135.2 | 130.8 | 125.6 | - | 115.8 | 68.4 | 39.9 | - | 32.3 | 38.7 | 52.1 | - | 34.2 | 52.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD